A single daily preventer dose of inhaled corticosteroid (beclomethasone), taken at mid-afternoon, may be the best timing for ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPDNew phase 2 data for amlitelimab show ...

For mild to moderate asthma, mid-afternoon dosing of inhaled beclomethasone suppressed nocturnal lung function worsening compared with other dosing strategies, a small open-label trial showed.

Conclusions: COPD is a progressive disease, and available treatment options provide limited efficacy. Given its unique mechanism of action and improved adverse effect profile compared with ...

After clinical evaluation, patients who had severe asthma were given high-dose inhaled salbutamol and had an intravenous cannula inserted. Additional treatment consisted of intravenous ...

disease were 1 1/2 times more likely to also have COPD. Plus, the worse the gum disease, the worse the lung function, suggesting a direct correlation between the two. 5. Steam therapy. Steam therapy, ...

A PaO2 test measures partial pressure of oxygen, or PaO2—the oxygen pressure in arterial blood. The PaO2 reflects how well oxygen is able to move from the lungs to the blood. It is often altered by ...